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The success of ~er~~taneo~s tra~s~~rni~~a~ coronary a
s limited by abrupt vessel occlusion and late 
2). ~~tra~oro~ary stem placement is being 
actively ~mvestigated s treat entt for both of these adverse 
patients undergoing stent placement receive short-term 
treatment with heparin, dextran, as irin, dipy~da~~~e and 
warfarin. Bleeding at the site of v ular access, gastroin- 
testinal tract and retroperitoneum have been reported se- 
quelae of this profound inhibition of platelet and coagulation 
factor function (1,2). Hemorrhage of the airways has not 
been previously reported. We report severe pulmonary 
hemorrhage complicating intracoronary stem placement in
four patients. 
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ospital records of 88 
After vasctilar sheath insertion, 10, 
prolong the activated 
U of intravenous 
The activated clotting time is monitored, aud sheaths are 
pulled at a level of 22 emostasis i  obtained, an 
intravenous bolus of2 U of beparin isgiven, and 
an infusion of I, U/h is begun. Activated partial thro 
boplastin times ar, - monitored and the heparin infusion 
adjusted to maintain them between 60 and 90 s. Warfarh 
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1. Chest radiogaphs of patien!s with pulmonary hemor- 
. Chest radiographs were taken after symptom onset. Admis- 
sio;. radiographs in each patient were free of pulmonary infiltrates. 
Radiographs after pulmonary hemorrhage reveal new infiltrates in 
each patient. A,Patient 1; B, Patient 2; C, Patient 3; D, Patient 4. 
aspirin and dipyridamole are given daily. Intravenous dex- 
tmn is continued until the prothrombin time reaches an 
international ormalized ratio of 3. At that point, the heparin 
infusion is reduced by 50%. Heparin s discontinued the 
folltiwing day if the prothrombin time remains inthe desired 
range at tbe reduced heparin dose. Patients are discharged 
with warfarin, aspirin and dipyridamole astheir outpatient 
stent anticoagulation regimen. Patients with stenis placed 
emerg;ently receive the same anticoaeulation pr tocol with 
the exception that dextran is initiated at the time that the 
decision is made to place the stent, and warfarin and 
dipyridamole are begun the day of rather than the day before 
the procedure. 
Four patients were identified who fulfilled the criteria for 
Fulmonary hemorrhage after stent placement. 
-year old woman with a 4~pac~ye~ 
tory of smoking and normal left ventricular function un 
went coronq angioplasty of the proximal and midportions 
of the right coronary artery, which resulted in a large but 
non-flow-limiting dissection. Seven hours later she devel- 
oped Chest pain and was returned to the catbete~zatio~ 
laboratory, where the dissection was noted to have in- 
creased in size. A 3.5-mm Wiktor (Medtronic) stent, suc- 
cessfully placed in the proximal vessel, obliterated the false 
lumen. The next day the patient developed respiratory 
distress and hypoxemia (arterial blood gases: pH 7.29, 
partial pressure ofcarbon dioxide (Pco& 30 mm Hg, partial 
pressure ofoxygen (PO& 39 mm Hg). The prothrombin time 
was 26.3 s. and the partial thromboplastin time was >I80 s. 
She was initially treated with intravenous firosemide for 
presumed congestive heart failure without improvement. 
She subsequently developed hemcptysis and required intu- 
bation 8~~ mechanical ventilation for refractory hypoxemia. 
Chest radiograph revealed bilateral lveolar and interstitial 
infiltrates (Fig. 1A). A pulmonary artery catheter docu- 
mented a pulmonary capil?ary wedge pressure of 10 mm Hg 
and a puimonary artery pressure of3CQO mm Hg. Intrave- 
nous dextran was discontinued, and the heparin i fusion rate 
was reduced. Fiberoptic bronchoscopy was performed 48 h 
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throughout the airways without an active bleeding site. 
Hemoptysis gradually resolved, and the patient was dis- 
he 20th ospital day. 
A 77-year old nonsmoking man with chronic 
renal insufficiency presented for elective 3.5mm Wiktor 
stent placement at a site of restenosis from a previous 
coronary angiopiasty in the saphenous vein graft o the left 
circumflex coronary artery. Eight hours after the successful 
procedure, the patient developed tachypcea, bemo~tysis 
and bilateral pdimonary rales thought to represent volume 
overload. Arterial blood gases on 6 liters/ 
veaied pH 7.29, Pco, 34 mm 
Prothrombin time was 15.9 s, 
partial thromboplastin timewas >180 s. Pulmonary artery 
catheterization uetermined a pulmonary artery p essure of 
27/M mm Hg and a pulmonary capillary wedge pressure of 
11 mm Hg. Diffuse alveolar infiltrates were present biiater- 
days. The average duration of time in the intensive care unit 
was 16 days. The mean duration of hospital stay was 22 days 
compared with a mean of 7days in patients with stems who 
do not experience this complication. One of the four patients 
osslble t~o~~g~es of put age. Previous 
reports of pulmonary hemorrhage have found it to be asso- 
ciated with intrinjrc lung disease (3). This etiology isunhkeiy 
in the patients described h rein, because only e smoked 
cigarettes, and the other three were without any history of
pulmonary disease. In the absence of ~reexistiflg iuug dis- 
ease, pulmonary hemorrhage has been associated with 
pathologic coaguiopathies, a  occur in acute leukemia, or 
those induced by warfarin and heparin therapy (4,5). 
ever, given the widespread nd io~~stand~n~ use of inten- 
sive anticoagulation and the rarity of associated pulmonary 
hemorrhage, it has been speculated that in patients receiving 
anticoagulation or in those with a coagulopathy, concomi- 
tant lung injury or elevated pulmonary venous pressure is 
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required to produce clinically significant pulmonary hemor- 
rhage (4). Because our patients had noevidence of pulmo- 
nary venous hypertension, the issue of lung injury becomes 
pertinent. All patients were receiving intravenous dextran at 
the time of symptom onset. In addition to its anticoagulant 
properties, dextran h s been shown to elicit &G-mediated 
immune complex formation capable of resulting in lung 
injury (6). Thus, intravenous dextran may be responsible in 
susceptible patients for lung i jury that predisposes to pul- 
monary hemorrhage in the setting of intense anticoagulation. 
The intense antic ulation currently used 
seeks to balance the 
rombosis while mini- 
the development of pulmonary hemo~~a~e. There have 
been no controlled trials comparing different forms, st 
gies or intensities ofantic~~ulation on patient outcome 
stent placement. Given the morbidity and mortality associ- 
ated with both thrombotic and hemorrhagic complications of 
stent placement, the likelihood of more widespread use 
of stems after ecent FDA approval ofthe 
stent and the rne~i~g era of even more 
essary Qve~nticoa~~~ati~~ in pat 
onary stem placement. 
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